Zivo Bioscience Inc Cash Flow-to-Debt Ratio
Zivo Bioscience Inc cash flow-to-debt ratio. Zivo Bioscience Inc (ZIVO) has a Cash Flow-to-Debt Ratio of -0.05x as of March 2026, meaning its operating cash flow of $-210.70K could theoretically repay 0% of its total liabilities ($3.94 Million) in one year. Check ZIVO cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Zivo Bioscience Inc (2003–2025)
Cash flow-to-debt ratio of Zivo Bioscience Inc from 2003 to 2025. Historical debt coverage capacity for Zivo Bioscience Inc across 23 annual periods. Check ZIVO cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Zivo Bioscience Inc Cash Flow-to-Debt Ratio by Year (2003–2025)
Zivo Bioscience Inc cash flow-to-debt ratio by year from 2003 to 2025. Year-by-year debt coverage analysis for Zivo Bioscience Inc. For the full cash flow conversion analysis, see ZIVO operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.75x | $-3.29 Million | $4.41 Million | ▲ +62.7% |
| 2024 | -2.00x | $-4.31 Million | $2.16 Million | ▲ +4.8% |
| 2023 | -2.10x | $-5.80 Million | $2.76 Million | ▲ +36.9% |
| 2022 | -3.33x | $-7.10 Million | $2.13 Million | ▼ -44.2% |
| 2021 | -2.31x | $-6.80 Million | $2.95 Million | ▼ -928.1% |
| 2020 | -0.22x | $-2.59 Million | $11.53 Million | ▲ +47.3% |
| 2019 | -0.43x | $-3.71 Million | $8.71 Million | ▼ -93.0% |
| 2018 | -0.22x | $-5.01 Million | $22.69 Million | ▼ -6.7% |
| 2017 | -0.21x | $-4.24 Million | $20.51 Million | ▼ -16.8% |
| 2016 | -0.18x | $-2.54 Million | $14.36 Million | ▲ +26.2% |
| 2015 | -0.24x | $-2.30 Million | $9.57 Million | ▲ +43.2% |
| 2014 | -0.42x | $-2.74 Million | $6.47 Million | ▼ -66.6% |
| 2013 | -0.25x | $-2.99 Million | $11.77 Million | ▲ +40.0% |
| 2012 | -0.42x | $-1.77 Million | $4.19 Million | ▲ +18.4% |
| 2011 | -0.52x | $-1.29 Million | $2.49 Million | ▲ +53.5% |
| 2010 | -1.11x | $-1.44 Million | $1.29 Million | ▼ -305.8% |
| 2009 | -0.27x | $-1.15 Million | $4.19 Million | ▲ +72.0% |
| 2008 | -0.98x | $-935.82K | $954.74K | ▲ +28.2% |
| 2007 | -1.37x | $-1.41 Million | $1.03 Million | ▲ +24.5% |
| 2006 | -1.81x | $-2.09 Million | $1.15 Million | ▼ -37.1% |
| 2005 | -1.32x | $-1.65 Million | $1.25 Million | ▼ -19.1% |
| 2004 | -1.11x | $-1.28 Million | $1.16 Million | ▼ -191.6% |
| 2003 | -0.38x | $-17.39K | $45.78K | — |